B cells sustain inflammation and predict response to immune checkpoint blockade in human melanoma
Johannes Griss(European Bioinformatics Institute), Stephan N. Wagner(Medical University of Vienna)
Cited by 374
Related Papers
Tumor-associated B-cells induce tumor heterogeneity and therapy resistance
|Nature Communications|2017|141
MTSS1 is a metastasis driver in a subset of human melanomas
|Nature Communications|2014|63
NVP-LDE225, a Potent and Selective SMOOTHENED Antagonist Reduces Melanoma Growth In Vitro and In Vivo
|PLoS ONE|2013|48
Overcoming MITF-conferred drug resistance through dual AURKA/MAPK targeting in human melanoma cells
|Cell Death and Disease|2016|23